Cognition Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Cognition Therapeutics, Inc. (CGTX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $98.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-07
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $98.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $32.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $37.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $44.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $98.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $32.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $37.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $44.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $52.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $61.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $70.00K 10-K · filed 2025-03-20 |
| 2024-09-30 | $82.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $94.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $107.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $116.00K 10-K · filed 2024-03-26 |
| 2023-09-30 | $129.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $146.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $161.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $176.00K 10-K · filed 2023-03-23 |
| 2022-09-30 | $167.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $138.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $148.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |